e. coli 83972
Cell therapyexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2003 (NCT00927316)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e. coli 83972
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00371631 | Phase 1 | Oct 1, 2006 | Department of Veteran Affairs |
| NCT00927316 | N/A | Mar 1, 2003 | Coloplast A/S, Lund University, Region Skane, Swedish Institute for Infectious Disease Control |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Coloplast A/S | For profit | 1 | 0 | 1 | 2003 |
| Department of Veteran Affairs | Government | 1 | 1 | 1 | 2006 |
| Lund University | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Region Skane | Government | 1 | 1 | 1 | 2003 |
| Swedish Institute for Infectious Disease Control | Government | 1 | 0 | 1 | 2003 |
5 organizations
Page 1 / 1